Net Revenue of $23.1 Million, an 87% Increase over FY 2023 Net Revenue of $12.3 Million No Debt on Balance Sheet Following Conversion of $2.8 million in Senior Secured Convertible Notes New Pro-U.S.

TORONTO, March 3, 2025 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused ...

Conavi Medical Corp. (TSXV: CNVI) ("Conavi Medical” or the "Company”), a commercial stage medical device company focused on ...

The Finance Minister says the approval brings the total government guarantee exposure to $1.2 billion, equivalent to 8.2 ...

Councillor Maw told the same meeting that he thinks less is more for people he's spoken to in Scarborough: North Yorkshire ...